BR112015010704B8 - Partícula compósita, e, processo para preparar uma partícula compósita - Google Patents
Partícula compósita, e, processo para preparar uma partícula compósitaInfo
- Publication number
- BR112015010704B8 BR112015010704B8 BR112015010704A BR112015010704A BR112015010704B8 BR 112015010704 B8 BR112015010704 B8 BR 112015010704B8 BR 112015010704 A BR112015010704 A BR 112015010704A BR 112015010704 A BR112015010704 A BR 112015010704A BR 112015010704 B8 BR112015010704 B8 BR 112015010704B8
- Authority
- BR
- Brazil
- Prior art keywords
- composite particle
- particles
- ingestible
- nanoparticles
- composite
- Prior art date
Links
- 239000011246 composite particle Substances 0.000 title abstract 7
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000000463 material Substances 0.000 abstract 8
- 238000000034 method Methods 0.000 abstract 4
- 239000002245 particle Substances 0.000 abstract 4
- 239000002105 nanoparticle Substances 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 239000002552 dosage form Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- 238000005054 agglomeration Methods 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 239000012876 carrier material Substances 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/18—Processes for applying liquids or other fluent materials performed by dipping
- B05D1/22—Processes for applying liquids or other fluent materials performed by dipping using fluidised-bed technique
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261725301P | 2012-11-12 | 2012-11-12 | |
| US61/725,301 | 2012-11-12 | ||
| PCT/US2013/069128 WO2014074808A1 (en) | 2012-11-12 | 2013-11-08 | Pharmaceutical core-shell composite powder and processes for making the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112015010704A2 BR112015010704A2 (pt) | 2017-07-11 |
| BR112015010704B1 BR112015010704B1 (pt) | 2022-05-31 |
| BR112015010704B8 true BR112015010704B8 (pt) | 2022-06-14 |
Family
ID=50685172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015010704A BR112015010704B8 (pt) | 2012-11-12 | 2013-11-08 | Partícula compósita, e, processo para preparar uma partícula compósita |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9801820B2 (https=) |
| EP (1) | EP2916824B1 (https=) |
| JP (1) | JP6460562B2 (https=) |
| CN (1) | CN104968332B (https=) |
| AR (1) | AR093449A1 (https=) |
| BR (1) | BR112015010704B8 (https=) |
| DK (1) | DK2916824T3 (https=) |
| ES (1) | ES2745759T3 (https=) |
| WO (1) | WO2014074808A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10149826B2 (en) * | 2015-01-20 | 2018-12-11 | Hyalo Technologies, LLC | Method of preparing microspheres |
| WO2017047650A1 (ja) * | 2015-09-14 | 2017-03-23 | 大和製罐株式会社 | 粉末吸入剤、吸入器、及び粉末吸入剤の製造方法 |
| CN108024912A (zh) * | 2015-09-24 | 2018-05-11 | 荷兰联合利华有限公司 | 口腔护理组合物 |
| US9675609B2 (en) | 2015-11-11 | 2017-06-13 | Cao Pharmaceuticals Inc. | Nano- and micro-sized particles of 20-camptothecin or derivative thereof and pharmaceutical compositions containing same, and treatment of cancers therewith |
| JP6067154B1 (ja) * | 2016-01-25 | 2017-01-25 | 株式会社樋口商会 | コーティング粒子の製造方法 |
| KR101809139B1 (ko) | 2016-11-15 | 2017-12-15 | 주식회사 이코블록 | 무기물 코어에 유기물을 코팅하는 방법 및 그에 따른 용사코팅장치 |
| JP6935501B2 (ja) * | 2017-08-25 | 2021-09-15 | 福田金属箔粉工業株式会社 | 積層造形用粉末の評価方法 |
| DE102017215328A1 (de) * | 2017-09-01 | 2019-03-07 | Henkel Ag & Co. Kgaa | Treibmittelhaltige kosmetische Zusammensetzungen mit Pigment-haltigen Stärkepartikeln und anionischem Polymer |
| CN107649063B (zh) * | 2017-11-02 | 2023-08-29 | 黑龙江省科学院自动化研究所 | 一种纳米材料超声共振乳化混配装置 |
| US12097204B2 (en) | 2018-09-03 | 2024-09-24 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Solid pharmaceutical composition containing 1,3,5-triazine derivative or salt thereof |
| CN109046187B (zh) * | 2018-10-09 | 2023-05-23 | 天津西敦津洋环保科技有限公司 | 一种高充气率的气固流化床反应器、实现在流化床中高充气率的方法及其应用 |
| JP7147523B2 (ja) * | 2018-12-06 | 2022-10-05 | 三生医薬株式会社 | 造粒方法 |
| US11549381B2 (en) * | 2019-09-05 | 2023-01-10 | Raytheon Technologies Corporation | Coating fabrication method for producing engineered microstructure of silicate-resistant barrier coating |
| JP2023505142A (ja) * | 2019-12-02 | 2023-02-08 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 活性医薬成分のナノ懸濁液の担体上の堆積 |
| CN114786739B (zh) * | 2019-12-16 | 2023-10-31 | 固特异轮胎和橡胶公司 | 二氧化硅涂覆的淀粉 |
| KR20220144378A (ko) * | 2020-02-19 | 2022-10-26 | 나노 파마솔루션즈, 인코포레이티드 | 치료제 나노입자 및 제조 방법 |
| CN112522863B (zh) * | 2020-11-26 | 2021-12-07 | 内蒙古工业大学 | 气流铺覆纤维装置 |
| EP4507510A4 (en) * | 2022-04-10 | 2026-03-25 | Incredo Ltd | COATED SWEETENER PARTICLES |
| CN115386208B (zh) * | 2022-08-11 | 2025-06-24 | 长兴电子（苏州）有限公司 | 可降解微珠及其制备方法与应用 |
| TWI859571B (zh) * | 2022-08-29 | 2024-10-21 | 長興材料工業股份有限公司 | 可降解微珠及其製備方法與應用 |
| TWI842445B (zh) * | 2023-03-21 | 2024-05-11 | 國立臺灣海洋大學 | 含有褐藻萃取物的多層顆粒結構及其製造方法 |
| CN119555851B (zh) * | 2025-02-06 | 2025-06-03 | 上海新黄河制药有限公司 | 一种吸入用混悬液的体外溶出曲线测定方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| US7276249B2 (en) | 2002-05-24 | 2007-10-02 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
| JP4547888B2 (ja) * | 2003-10-10 | 2010-09-22 | 小野薬品工業株式会社 | 胃内浮遊性固形製剤 |
| US7402175B2 (en) | 2004-05-17 | 2008-07-22 | Massachusetts Eye & Ear Infirmary | Vision prosthesis orientation |
| KR20090005237A (ko) | 2006-05-22 | 2009-01-12 | 테바 파마슈티컬 인더스트리즈 리미티드 | 둘록세틴 염산염 지연 방출형 제제 |
| WO2008002568A2 (en) | 2006-06-26 | 2008-01-03 | Mutual Pharmaceutical Company, Inc. | Active agent formulations, methods of making, and methods of use |
| IL197129A (en) | 2006-08-25 | 2014-08-31 | Boehringer Ingelheim Int | Controlled release system and method for production |
| AU2007325628A1 (en) * | 2006-11-28 | 2008-06-05 | Marinus Pharmaceuticals | Nanoparticulate formulations and methods for the making and use thereof |
| US8993041B2 (en) * | 2012-10-15 | 2015-03-31 | New Jersey Institute Of Technology | Taste masked active pharmaceutical powder compositions and processes for making them |
-
2013
- 2013-11-08 US US14/441,970 patent/US9801820B2/en active Active
- 2013-11-08 ES ES13852722T patent/ES2745759T3/es active Active
- 2013-11-08 DK DK13852722.1T patent/DK2916824T3/da active
- 2013-11-08 CN CN201380059171.5A patent/CN104968332B/zh active Active
- 2013-11-08 WO PCT/US2013/069128 patent/WO2014074808A1/en not_active Ceased
- 2013-11-08 JP JP2015541920A patent/JP6460562B2/ja active Active
- 2013-11-08 BR BR112015010704A patent/BR112015010704B8/pt active IP Right Grant
- 2013-11-08 EP EP13852722.1A patent/EP2916824B1/en active Active
- 2013-11-12 AR ARP130104150A patent/AR093449A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2916824A1 (en) | 2015-09-16 |
| ES2745759T3 (es) | 2020-03-03 |
| EP2916824B1 (en) | 2019-06-19 |
| BR112015010704B1 (pt) | 2022-05-31 |
| WO2014074808A1 (en) | 2014-05-15 |
| CN104968332B (zh) | 2020-10-20 |
| CN104968332A (zh) | 2015-10-07 |
| EP2916824A4 (en) | 2016-08-17 |
| US9801820B2 (en) | 2017-10-31 |
| DK2916824T3 (da) | 2019-09-30 |
| AR093449A1 (es) | 2015-06-10 |
| JP6460562B2 (ja) | 2019-01-30 |
| US20150297521A1 (en) | 2015-10-22 |
| JP2016503411A (ja) | 2016-02-04 |
| BR112015010704A2 (pt) | 2017-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015010704B8 (pt) | Partícula compósita, e, processo para preparar uma partícula compósita | |
| AR087665A1 (es) | Particula de suministro, composiciones para el tratamiento de superficies que comprenden agentes de beneficios dirigidos, proceso para su produccion | |
| BR112017012363A8 (pt) | Microcápsulas revestidas, seu uso e produto de consumo que as compreende | |
| BR112015012469A2 (pt) | pó formado de partículas, mais do que 95% em número de ditas partículas exibindo uma circularidade superior ou igual a 0,85, processo para a fabricação de um pó, processo de pulverização térmica e câmara de tratamento para semicondutores | |
| BR112015028883A2 (pt) | encapsulados | |
| JP2013521533A5 (https=) | ||
| HK1212724A1 (zh) | 多层包覆的量子点珠 | |
| BR112015028564A2 (pt) | encapsulados | |
| WO2013132491A3 (en) | Coating layers of a nanocomposite comprising a nano-cellulose material and nanoparticles | |
| BR112018006221A2 (pt) | cápsula híbrida, método para preparar uma cápsula híbrida, e, produto destinado ao consumidor | |
| BRPI1013021A2 (pt) | "material compósito que compreende nanopartículas, e produção de camadas fotoativas que contêm nanopartículas semicondutoras quaternárias, pentanárias ou de ordem mais alta" | |
| ATE492610T1 (de) | Photoaktives tio2 in beschichtungsmaterialien | |
| AR087664A1 (es) | Mejoras relacionadas con composiciones para el tratamiento de superficies que comprenden agentes de beneficio direccionados | |
| WO2011008461A3 (en) | Ceramic honeycomb structure with applied inorganic skin | |
| BR112014032984A2 (pt) | nanocompósito e método de fabricar o mesmo | |
| CO7141472A2 (es) | Tratamiento de materiales que contienen carbonato de calcio para carga de agente de relleno aumentada en papel | |
| JP2013511602A5 (https=) | ||
| BR112019015439A2 (pt) | Compósito tipo folha, método e uso do compósito tipo folha | |
| BR112015006017A2 (pt) | estabilização de sistemas de cápsulas em produtos de lavagem e outros produtos de limpeza | |
| BR112015023728A2 (pt) | compósito, processo para preparação de um compósito, produto de consumo, uso de um compósito, e, método para preparação de um produto | |
| CL2014001318A1 (es) | Articulo absorbente que comprende un nucleo absorbente que tiene un grosor en seco en el punto de entrepierna del articulo de 0,2 a 5 mm, en donde una o mas porciones de la estructura absorbente contiene al menos 90% en peso de particulas de polimero superabsorbente. | |
| BR112012033806A2 (pt) | composição na forma de uma partícula, método para sua preparação e uso da composição | |
| UY35824A (es) | Preparación farmacéutica y forma de su producción y uso | |
| EP3435460A4 (en) | CARRIER NANOPARTICLE COMPOSITE, CATALYST THEREOF AND METHOD FOR THE PRODUCTION THEREOF | |
| IT201700067430A1 (it) | Nanoparticelle quali veicoli di rilascio di principi attivi e metodi per la loro produzione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/11/2013, OBSERVADAS AS CONDICOES LEGAIS |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2682 DE 31/05/2022 QUANTO AO ENDERECO. |